Yi Zhe Wang
Net worth: - $ as of 2024-04-29
Profile
Yi Zhe Wang served as the Chief Executive Officer & Director at LianBio from 2021 to 2023.
Prior to that, he was the Senior VP-BioMedicines & Oncology Businesses at Lilly China Research & Development Co. Ltd.
from 2018 to 2020.
Wang holds a doctorate from Yale University, an undergraduate degree from Ramapo College of New Jersey, and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LIANBIO
-.--% | 2023-04-09 | 0 ( -.--% ) | - $ | 2024-04-29 |
Former positions of Yi Zhe Wang
Companies | Position | End |
---|---|---|
LIANBIO | Chief Executive Officer | 2023-12-15 |
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Corporate Officer/Principal | 2020-04-30 |
Training of Yi Zhe Wang
Yale University | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ramapo College of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LIANBIO | Health Technology |
Private companies | 1 |
---|---|
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Yi Zhe Wang